We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current APRE market cap is 21.49M. The company's latest EPS is USD -3.8235 and P/E is -1.50.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 250k | 319k |
Operating Income | -4.2M | -2.65M | -4.62M | -3.65M | -3.52M |
Net Income | -4.03M | -2.44M | -4.38M | -3.26M | -3.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 583k |
Operating Income | -29.54M | -52.81M | -37.45M | -113.39M | -15.47M |
Net Income | -28.06M | -53.48M | -37.13M | -112.66M | -14.29M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 33.62M | 30.16M | 32.02M | 28.68M | 25.77M |
Total Liabilities | 4M | 3.2M | 4.23M | 3.95M | 4.17M |
Total Equity | 26.63M | 25.64M | 26.48M | 23.42M | 20.29M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 133.61M | 92.81M | 56.82M | 30.16M | 22.65M |
Total Liabilities | 9.36M | 15.41M | 7.32M | 3.2M | 4.39M |
Total Equity | 124.24M | 77.4M | 49.51M | 25.64M | 16.95M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.99M | -25.01M | -2.98M | -6.2M | -8.44M |
Investing | N/A | N/A | N/A | N/A | -86k |
Financing | 585k | 683k | 5.14M | 5.14M | 5.14M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -26.71M | -41.8M | -37.69M | -25.01M | -12.18M |
Investing | -31k | -26k | N/A | N/A | -93k |
Financing | 92.58M | 151k | 1.75M | 683k | 5.14M |
Market Cap | 21.49M |
Price to Earnings Ratio | -1.50 |
Price to Sales Ratio | 36.73 |
Price to Cash Ratio | 0.99 |
Price to Book Ratio | 1.17 |
Dividend Yield | - |
Shares Outstanding | 3.74M |
Average Volume (1 week) | 4.82k |
Average Volume (1 Month) | 11.75k |
52 Week Change | 41.98% |
52 Week High | 8.8465 |
52 Week Low | 2.78 |
Spread (Intraday) | 0.25 (4.17%) |
Company Name | Aprea Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aprea.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions